AR122394A2 - Caseinsuccinilato de hierro (iii), método para prepararlo y composición farmacéutica que lo contiene - Google Patents

Caseinsuccinilato de hierro (iii), método para prepararlo y composición farmacéutica que lo contiene

Info

Publication number
AR122394A2
AR122394A2 ARP210100656A ARP210100656A AR122394A2 AR 122394 A2 AR122394 A2 AR 122394A2 AR P210100656 A ARP210100656 A AR P210100656A AR P210100656 A ARP210100656 A AR P210100656A AR 122394 A2 AR122394 A2 AR 122394A2
Authority
AR
Argentina
Prior art keywords
iron
caseinsuccinylate
iii
preparing
pharmaceutical composition
Prior art date
Application number
ARP210100656A
Other languages
English (en)
Inventor
Barbara Pinto
Andrea Stevenazzi
Ferra Lorenzo De
Original Assignee
Italfarmaco Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Italfarmaco Spa filed Critical Italfarmaco Spa
Publication of AR122394A2 publication Critical patent/AR122394A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
    • C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4732—Casein

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Caseinsuccinilato de hierro (III) que tiene un contenido de hierro comprendido entre 4,5 y 7% por peso, por una solubilidad mayor a aproximadamente 92% y por poseer una proporción de fósforo / nitrógeno mayor a aproximadamente el 5% por peso, preferentemente mayor a aproximadamente 5,5% por peso; método para prepararlo; y composición farmacéutica que lo contiene.
ARP210100656A 2010-06-30 2021-03-15 Caseinsuccinilato de hierro (iii), método para prepararlo y composición farmacéutica que lo contiene AR122394A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IT2010/000287 WO2012001712A1 (en) 2010-06-30 2010-06-30 Iron (iii) caseinsuccinylate and method for the preparation thereof

Publications (1)

Publication Number Publication Date
AR122394A2 true AR122394A2 (es) 2022-09-07

Family

ID=43302532

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP210100656A AR122394A2 (es) 2010-06-30 2021-03-15 Caseinsuccinilato de hierro (iii), método para prepararlo y composición farmacéutica que lo contiene

Country Status (20)

Country Link
US (1) US20130102529A1 (es)
EP (1) EP2588488B1 (es)
KR (1) KR101701830B1 (es)
CN (2) CN107090011A (es)
AR (1) AR122394A2 (es)
BR (1) BR112012032364B1 (es)
CY (1) CY1119054T1 (es)
DK (1) DK2588488T3 (es)
ES (1) ES2628306T3 (es)
HR (1) HRP20170541T1 (es)
HU (1) HUE032746T2 (es)
LT (1) LT2588488T (es)
MA (1) MA34319B1 (es)
MX (1) MX346317B (es)
PL (1) PL2588488T3 (es)
PT (1) PT2588488T (es)
RS (1) RS55978B1 (es)
RU (1) RU2533826C2 (es)
SI (1) SI2588488T1 (es)
WO (1) WO2012001712A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102836419B (zh) * 2012-09-25 2014-06-25 济川药业集团有限公司 一种蛋白琥珀酸铁口服溶液及其制备方法
CN108498454B (zh) * 2018-04-03 2020-11-06 济川药业集团有限公司 一种蛋白琥珀酸铁口服液及其制备方法
CN111000977A (zh) * 2019-03-22 2020-04-14 江苏中天药业有限公司 一种蛋白琥珀酸铁固体新剂型及其制备方法
CN112063676B (zh) * 2020-09-02 2021-11-12 杭州汉库医药科技有限公司 酪蛋白纯化方法和蛋白琥珀酸铁的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1150213B (it) * 1982-03-02 1986-12-10 Italfarmaco Spa Derivati di ferro biodisponibile esenti da gastrolesivita',procentimento di preparazione e relative composizioni farmaceutiche
IT1222912B (it) 1987-10-14 1990-09-12 Italfarmaco Spa Derivati polipeptidici a elevato tenore di ferro e altamente solubili atti alla terapia marziale procedimenti di preparazione e loro forme farmaceutiche
IT1297022B1 (it) * 1997-12-24 1999-08-03 Chemi Spa Complesso di ferro-succinilcaseina, processo per la sua preparazione e composizioni farmaceutiche che lo contengono
ITMO20040200A1 (it) 2004-07-29 2004-10-29 Biofer Spa Processo per la produzione di complessi ferro succinilcaseina e ferro casein acetil aspartilato e loro utilizzato nelle relative composizioni farmaceutiche.
DK1968996T3 (da) * 2005-12-06 2009-12-21 Vifor Int Ag Fremgangsmåde til fremstilling af ferri-succinylkasein
US20070281055A1 (en) * 2006-06-02 2007-12-06 Patel Gaurav C Protein Ingredient with Improved Sensory Quality and Nutritionals with Improved Flavor Containing Same
TWI346666B (en) * 2007-12-31 2011-08-11 Animal Technology Inst Taiwan Method for seperating casein from casein-contained solution

Also Published As

Publication number Publication date
PT2588488T (pt) 2017-06-26
HRP20170541T1 (hr) 2017-06-16
WO2012001712A1 (en) 2012-01-05
US20130102529A1 (en) 2013-04-25
LT2588488T (lt) 2017-05-10
CY1119054T1 (el) 2018-01-10
KR101701830B1 (ko) 2017-02-13
CN103025751B (zh) 2016-12-21
PL2588488T3 (pl) 2017-09-29
RU2533826C2 (ru) 2014-11-20
CN107090011A (zh) 2017-08-25
MA34319B1 (fr) 2013-06-01
MX346317B (es) 2017-03-15
BR112012032364B1 (pt) 2021-08-31
BR112012032364A2 (pt) 2016-10-04
RS55978B1 (sr) 2017-09-29
KR20130136422A (ko) 2013-12-12
EP2588488A1 (en) 2013-05-08
RU2013103799A (ru) 2014-08-10
CN103025751A (zh) 2013-04-03
HUE032746T2 (en) 2017-10-30
ES2628306T3 (es) 2017-08-02
DK2588488T3 (en) 2017-04-03
SI2588488T1 (sl) 2017-07-31
MX2012014199A (es) 2013-05-06
EP2588488B1 (en) 2017-03-15

Similar Documents

Publication Publication Date Title
AR122394A2 (es) Caseinsuccinilato de hierro (iii), método para prepararlo y composición farmacéutica que lo contiene
JOP20180102B1 (ar) مركب صيدلاني
PH12014502602B1 (en) Methods for improving safety of blood-brain barrier transport
ECSP13012534A (es) Composición farmacéutica
AR081558A1 (es) Extraccion de lipidos de celulas y productos provenientes de ellos
EA201491195A1 (ru) Способ получения композиции, содержащей галактоолигосахариды
EA201590887A1 (ru) Композиция
PH12015500900A1 (en) A stabilized pemetrexed formulation
UA111717C2 (uk) Склад для перорального введення і ліпофільні солі метилналтрексону
BR112015001414A2 (pt) composição antideriva
JO3154B1 (ar) عوامل مضادة لـ trpv4
BR112013001109A2 (pt) composição que contém galacto-oligossacarídeos e método para produzi-la
DOP2013000293A (es) Composiciones líquidas de limpieza de sal
PH12014502858A1 (en) Racecadotril lipid compositions
MX2016008369A (es) Composicion farmaceutica que incluye palonosetron.
PH12014502856B1 (en) Solid pharmaceutical preparation containing levothyroxine
MX2016003566A (es) Composicion que contiene polietilen glicol.
BR112014029264A2 (pt) microcápsulas contendo um oxidável ativa, e um processo para a preparação do mesmo
MX2015015247A (es) Metodo para estabilizar una composicion que contiene al menos un producto de deshidratacion interna de un azucar hidrogenado, composicion resultante y usos de esta.
PH12014502326A1 (en) A composition compromising amlodipine and losartan having an improved stability
IN2012DE00826A (es)
TR201104864A2 (tr) Deksketoprofen içeren suda çözünebilir formülasyonlar.
MX2013007000A (es) Proceso para encapsular ingrediente activo.
MX2015004313A (es) Formulacion de aroma y fragancia (ii).
MX2013014768A (es) Mezclas de colorante acido para poliamida y lana.